A new study co-led by Scintillon Institute’s Associate Professor, Dr. Rajesh Ambasudhan, and Adjunct Professor Dr. Stuart Lipton (also a practicing Neurologist at UC San Diego) shows that certain immunotherapy approaches for Parkinson’s disease (PD) may cause harmful neuroinflammation by activating microglia (brain’s immune cells) and that this adverse effect could offset therapeutic benefits elicited by the antibody treatment. The study appeared in the April 13, 2021 issue of the Proceedings of the National Academy of Science of the United States of America.